menu
    • menu

    Company profile for A2 Biotherapeutics

    NEW Drugs in Dev: 3
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander K...
    A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and raised a Series A financing of $57 million. We are currently advancing a pipeline of programs towards the clinic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    A2 BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    30301 Agoura Road #210, Agoura Hills, CA, 91301
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.a2bio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/a2-biotherapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    A2 Bio Reports First CAR-T Complete Response in NSCLC at ASCO
    A2 Bio Reports First CAR-T Complete Response in NSCLC at ASCO

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260515085966/en/A2-Biotherapeutics-Presents-Safety-and-Efficacy-Data-from-the-EVEREST-2-Clinical-Study-Including-Update-on-the-First-Complete-Response-to-CAR-T-Cell-Therapy-in-a-Patient-with-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    21 May 2026
    Share Share
    A2 Bio Gets FDA Fast Track for Logic-Gated CAR-T A2B543
    A2 Bio Gets FDA Fast Track for Logic-Gated CAR-T A2B543

    01 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260331789509/en/A2-Biotherapeutics-Receives-U.S.-FDA-Fast-Track-Designation-for-A2B543-a-Logic-Gated-CAR-T-Cell-Therapy-Enhanced-with-a-Membrane-Tethered-IL-12-Booster

    BUSINESSWIRE
    01 Apr 2026
    Share Share
    A2 Bio Doses First Patient in EVEREST-2 Study with A2B543
    A2 Bio Doses First Patient in EVEREST-2 Study with A2B543

    26 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260225216939/en/A2-Biotherapeutics-Doses-First-Patient-in-EVEREST-2-Study-with-A2B543-a-Logic-Gated-CAR-T-Cell-Therapy-Enhanced-with-a-Membrane-Tethered-IL-12-Booster

    BUSINESSWIRE
    26 Feb 2026
    Share Share
    A2 Biotherapeutics Clears FDA IND For A2B543
    A2 Biotherapeutics Clears FDA IND For A2B543

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106828941/en/A2-Biotherapeutics-Announces-FDA-Clearance-of-IND-for-A2B543-for-Treatment-of-Adults-with-Recurrent-Unresectable-Locally-Advanced-or-Metastatic-Solid-Tumors-that-Express-Mesothelin-and-Have-Lost-HLA-A02-Expression

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    A2 Bio Presents Safety & Efficacy Data From EVEREST-2 Study
    A2 Bio Presents Safety & Efficacy Data From EVEREST-2 Study

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031980313/en/A2-Biotherapeutics-Presents-Initial-Safety-and-Efficacy-Data-from-Ongoing-Phase-12-EVEREST-2-Study-Including-First-Report-of-a-Complete-Response-to-CAR-T-Cell-Therapy-in-a-Patient-with-NSCLC

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    A2 Bio To Unveil EVEREST-2 Study Data At 2025 SITC Meeting
    A2 Bio To Unveil EVEREST-2 Study Data At 2025 SITC Meeting

    03 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251001069413/en/A2-Bio-to-Present-Early-Safety-and-Efficacy-Data-from-EVEREST-2-Study-during-2025-Annual-Meeting-of-the-Society-for-Immunotherapy-of-Cancer

    BUSINESSWIRE
    03 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search